Two new indications for pembrolizumab have been approved in Russia

समान संसाधन

• New indications for the use of pembrolizumab in Russia: the use of the drug in the 1st line of treatment of recurrent and metastatic head and neck squamous cell carcinoma in single mode and in combination with chemotherapy has been approved
  द्वारा: Article Editorial
  प्रकाशित: (2020-11-01)
• The drug for repletion of the lack of growth hormone has been approved in the United States
  द्वारा: article Editorial
  प्रकाशित: (2023-08-01)
• Proceedings of the Expert Council “Treatment of inoperable endometrial cancer in Russia: issues that have not yet been addressed”
  द्वारा: article Editorial
  प्रकाशित: (2021-06-01)
• Consolidated list of products whose consumption and/or sale have been banned, withdrawn, severely restricted or not approved by governments.
• The world's first topical gene therapy drug for epidermolysis bullosa patients has been approved
  द्वारा: article Editorial
  प्रकाशित: (2023-07-01)